299 related articles for article (PubMed ID: 35396940)
21. Ginsenoside Rg1 fails to rescue PTSD-like behaviors in a mice model of single-prolonged stress.
Sun W; Zhang F; Wang H; Wang C; Zhou Z; Zhou Y
Biochem Biophys Res Commun; 2020 Jul; 528(2):243-248. PubMed ID: 32482388
[TBL] [Abstract][Full Text] [Related]
22. Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.
Lee JLC; Bertoglio LJ; Guimarães FS; Stevenson CW
Br J Pharmacol; 2017 Oct; 174(19):3242-3256. PubMed ID: 28268256
[TBL] [Abstract][Full Text] [Related]
23. Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial.
Telch MJ; Fischer CM; Zaizar ED; Rubin M; Papini S
Contemp Clin Trials; 2022 Nov; 122():106933. PubMed ID: 36154908
[TBL] [Abstract][Full Text] [Related]
24. Effects of ∆
Raymundi AM; da Silva TR; Sohn JMB; Bertoglio LJ; Stern CA
BMC Psychiatry; 2020 Aug; 20(1):420. PubMed ID: 32842985
[TBL] [Abstract][Full Text] [Related]
25. Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction.
Franzen JM; Vanz F; Werle I; Guimarães FS; Bertoglio LJ
Eur Neuropsychopharmacol; 2022 Nov; 64():7-18. PubMed ID: 36049316
[TBL] [Abstract][Full Text] [Related]
26. Potential Utility of Cannabidiol in Stress-Related Disorders.
Lookfong NA; Raup-Konsavage WM; Silberman Y
Cannabis Cannabinoid Res; 2023 Apr; 8(2):230-240. PubMed ID: 36409719
[No Abstract] [Full Text] [Related]
27. Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder.
Pang L; Zhu S; Ma J; Zhu L; Liu Y; Ou G; Li R; Wang Y; Liang Y; Jin X; Du L; Jin Y
Acta Pharm Sin B; 2021 Jul; 11(7):2031-2047. PubMed ID: 34386336
[TBL] [Abstract][Full Text] [Related]
28. Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.
Raut SB; Marathe PA; van Eijk L; Eri R; Ravindran M; Benedek DM; Ursano RJ; Canales JJ; Johnson LR
Pharmacol Ther; 2022 Nov; 239():108195. PubMed ID: 35489438
[TBL] [Abstract][Full Text] [Related]
29. Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction.
Kwee CMB; van der Flier FE; Duits P; van Balkom AJLM; Cath DC; Baas JMP
Psychopharmacology (Berl); 2024 Apr; 241(4):833-847. PubMed ID: 38044339
[TBL] [Abstract][Full Text] [Related]
30. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cannabidiol to citalopram in targeting fear memory in female mice.
Montoya ZT; Uhernik AL; Smith JP
J Cannabis Res; 2020 Dec; 2(1):48. PubMed ID: 33526146
[TBL] [Abstract][Full Text] [Related]
32. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T
Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743
[TBL] [Abstract][Full Text] [Related]
33. Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice.
Assareh N; Gururajan A; Zhou C; Luo JL; Kevin RC; Arnold JC
Behav Pharmacol; 2020 Sep; 31(6):591-596. PubMed ID: 32483052
[TBL] [Abstract][Full Text] [Related]
34. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments.
Bayer H; Stern CAJ; Troyner F; Gazarini L; Guimarães FS; Bertoglio LJ
Neuropharmacology; 2022 Mar; 205():108913. PubMed ID: 34864001
[TBL] [Abstract][Full Text] [Related]
35. Midazolam ameliorates the behavior deficits of a rat posttraumatic stress disorder model through dual 18 kDa translocator protein and central benzodiazepine receptor and neurosteroidogenesis.
Miao YL; Guo WZ; Shi WZ; Fang WW; Liu Y; Liu J; Li BW; Wu W; Li YF
PLoS One; 2014; 9(7):e101450. PubMed ID: 24988461
[TBL] [Abstract][Full Text] [Related]
36. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats.
Resstel LB; Joca SR; Moreira FA; Corrêa FM; Guimarães FS
Behav Brain Res; 2006 Sep; 172(2):294-8. PubMed ID: 16780966
[TBL] [Abstract][Full Text] [Related]
37. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.
Forsythe ML; Boileau AJ
J Basic Clin Physiol Pharmacol; 2021 Mar; 33(2):121-132. PubMed ID: 33662194
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of morphine in a rat model of post-traumatic stress disorder: Role of hypothalamic-pituitary-adrenal axis and beta- adrenergic system.
Abdullahi PR; Raeis-Abdollahi E; Sameni H; Vafaei AA; Ghanbari A; Rashidy-Pour A
Behav Brain Res; 2020 Oct; 395():112867. PubMed ID: 32827567
[TBL] [Abstract][Full Text] [Related]
39. Influence of early stress on memory reconsolidation: Implications for post-traumatic stress disorder treatment.
Villain H; Benkahoul A; Birmes P; Ferry B; Roullet P
PLoS One; 2018; 13(1):e0191563. PubMed ID: 29352277
[TBL] [Abstract][Full Text] [Related]
40. Cannabidiol enhances consolidation of explicit fear extinction in humans.
Das RK; Kamboj SK; Ramadas M; Yogan K; Gupta V; Redman E; Curran HV; Morgan CJ
Psychopharmacology (Berl); 2013 Apr; 226(4):781-92. PubMed ID: 23307069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
